TLR Ligand-Based Solutions for Sustainable Agriculture and Environmental Remediation

Publication ID: 24-11857577_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “TLR Ligand-Based Solutions for Sustainable Agriculture and Environmental Remediation,” Published Technical Disclosure No. 24-11857577_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857577_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,577.

Summary of the Inventive Concept

This inventive concept leverages the core technology of toll-like receptor (TLR) ligands to develop novel applications in agriculture, environmental remediation, and biogas production, providing a sustainable and efficient solution for various industries.

Background and Problem Solved

The original patent focused on treating hepatic diseases and disorders. However, the limitations of this approach were its narrow application scope and lack of consideration for other industries. The new inventive concept addresses these limitations by applying the TLR ligand technology to tackle pressing issues in agriculture, environmental remediation, and biogas production, such as crop yield prediction, soil health improvement, bioremediation, disease detection in livestock, and biogas production efficiency.

Detailed Description of the Inventive Concept

The new inventive concept comprises a range of solutions utilizing TLR ligands to activate immune responses, stimulate beneficial microbial growth, and detect disease biomarkers. For instance, a system for monitoring and predicting crop yields uses a plant disease detection module with a TLR ligand to identify disease biomarkers in plant tissue. Similarly, a method for reducing environmental impact applies a pharmaceutical composition comprising a lysate and/or cell wall extract from a Gram-positive bacterium to soil, stimulating beneficial microbial growth and improving soil health. Other embodiments include a bioremediation system, a diagnostic kit for detecting diseases in livestock, and a method for improving biogas production efficiency.

Novelty and Inventive Step

The new claims introduce a paradigm shift by applying the TLR ligand technology to entirely new fields, including agriculture, environmental remediation, and biogas production. The inventive step lies in the recognition of the potential of TLR ligands to address pressing issues in these industries, and the development of novel solutions that leverage this technology.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include using different types of TLR ligands, modifying the composition and delivery of the pharmaceutical compositions, or integrating the TLR ligand technology with existing agricultural practices or biogas production methods. Variations could also include applying the technology to other industries, such as wastewater treatment or biofuel production.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the agriculture, environmental remediation, and biogas production industries. The market for sustainable agricultural practices, bioremediation solutions, and efficient biogas production is growing rapidly, and the TLR ligand-based solutions could capture a substantial share of this market. The technology could be licensed to companies operating in these industries, or Labyrinth Holdings, LLC could develop and market the solutions itself.

Field of Art

Biotechnology and pharmaceutical sciences, with expertise in immunological receptor technologies, specifically toll-like receptor (TLR) and Nod-like receptor (NLR) activation systems for therapeutic and diagnostic applications

Person of Ordinary Skill (PHOSITA) Profile

A researcher or biotechnology professional with advanced degree (PhD or equivalent) in microbiology, immunology, or pharmaceutical sciences, possessing knowledge of receptor activation mechanisms, bacterial lysate technologies, and interdisciplinary applications of immunological modulators

Obviousness Rationale

The PTD represents a predictable extension of the source patent's core TLR ligand technology by applying the fundamental immunological activation mechanism to alternative domains. A PHOSITA would recognize that the underlying molecular principles of TLR/NLR activation are transferable across biological systems, making the agricultural and environmental applications a logical and obvious technological progression from the original hepatic disease treatment approach.

Obvious Combinations & Variations

Source Patent Element
Lysate and/or cell wall extract from Gram-positive bacterium with TLR ligand activation
PTD Variation
Applying TLR ligand compositions to soil microbial stimulation and agricultural disease detection
Obviousness Reasoning
Known technique of leveraging immunological receptor activation in different biological contexts, with predictable results of microbial response and disease marker identification
Source Patent Element
Pharmaceutical composition targeting receptor activation mechanisms
PTD Variation
Extending receptor activation technology to bioremediation and biogas production systems
Obviousness Reasoning
Finite set of identifiable applications for TLR/NLR activation technology across biological systems, representing an obvious design choice for a skilled practitioner
Source Patent Element
Method of detecting disease biomarkers using receptor activation
PTD Variation
Developing diagnostic kit for livestock disease detection using similar TLR ligand principles
Obviousness Reasoning
Predictable adaptation of existing diagnostic methodology to a related biological domain, utilizing well-understood immunological detection mechanisms
35 U.S.C. § 103 Summary: Based on US Patent 11857577's disclosure of TLR ligand compositions, the present publication demonstrates that a person having ordinary skill in the art would find the agricultural, environmental, and diagnostic applications herein to be obvious variations of the fundamental receptor activation technology, thereby establishing prior art that would render analogous patent claims obvious and non-patentable.

Original Patent Information

Patent NumberUS 11,857,577
TitleCompositions and methods for the treatment of hepatic diseases and disorders
Assignee(s)Labyrinth Holdings, LLC